Tenet Healthcare Corporation $THC Shares Sold by Sanctuary Advisors LLC

Sanctuary Advisors LLC lessened its holdings in Tenet Healthcare Corporation (NYSE:THC) by 21.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,843 shares of the company’s stock after selling 3,308 shares during the period. Sanctuary Advisors LLC’s holdings in Tenet Healthcare were worth $2,353,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in THC. NewEdge Advisors LLC boosted its position in Tenet Healthcare by 6.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp boosted its position in Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after buying an additional 1,274 shares during the period. Sivia Capital Partners LLC purchased a new position in Tenet Healthcare in the 2nd quarter valued at approximately $290,000. Quantbot Technologies LP purchased a new position in Tenet Healthcare in the 2nd quarter valued at approximately $65,000. Finally, Amundi boosted its position in Tenet Healthcare by 4,207.8% in the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after buying an additional 26,383 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 earnings beat and solid profitability — Tenet reported $4.82 EPS, well ahead of consensus, and showed healthy margins and ROE; investors favor the earnings beat even though revenue was roughly in-line. Tenet Healthcare (THC) Q1 Earnings Top Estimates
• Positive Sentiment: Strategic growth via ASC acquisitions — Tenet deployed ~$125M to acquire seven ambulatory surgery centers in Q1 and signals more M&A in the outpatient space, supporting revenue diversification and higher-margin outpatient growth. Tenet deployed $125M on 7 ASC acquisitions in Q1, eyes more deals
• Positive Sentiment: Operational momentum in procedures and robotics — The company is seeing double?digit joint replacement growth and expanding robotic programs across ASCs/hospitals, evidence that its outpatient acuity push is producing revenue mix benefits longer term. Double-digit joint replacement growth
• Neutral Sentiment: Analysts trimmed price targets but kept Buy/Outperform/Overweight ratings — Multiple firms cut PTs (RBC to $236, Guggenheim to $252, Wells Fargo to $213, KeyCorp to $225) while retaining positive ratings, which gives the stock continued sell?side endorsement but signals more conservative valuation assumptions. Analyst price target coverage (Benzinga summaries) TickerReport coverage
• Neutral Sentiment: Market commentary and investor takeaways — Several pieces are advising investors to weigh analyst views and the company’s outpatient strategy at current levels; these articles are shaping investor positioning rather than delivering new fundamental news. Seeking Alpha: Investor commentary
• Negative Sentiment: Revenue softness and admissions?mix headwinds — Management flagged admissions mix and external disruptions as reasons revenue missed expectations modestly; that weak revenue signal tempers the EPS beat and is the main near-term risk. Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales

Insider Activity at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the sale, the executive vice president directly owned 12 shares of the company’s stock, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 46,517 shares of company stock valued at $10,943,111 over the last ninety days. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $183.23 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.68 and a debt-to-equity ratio of 1.96. The firm has a fifty day moving average price of $207.31 and a 200 day moving average price of $204.27. The company has a market cap of $16.05 billion, a P/E ratio of 9.53, a PEG ratio of 1.37 and a beta of 1.30. Tenet Healthcare Corporation has a 12 month low of $145.27 and a 12 month high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period in the previous year, the company earned $4.36 earnings per share. Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts predict that Tenet Healthcare Corporation will post 17.42 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on THC. Guggenheim decreased their price target on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research report on Friday. Leerink Partners boosted their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. Royal Bank Of Canada lowered their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday. Wells Fargo & Company lowered their target price on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research note on Friday. Finally, Truist Financial boosted their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $241.94.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.